Faculty profile

Dina Kao

ResearcherMedicineUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.

Dina Kao

Researcher

Medicine

Health Sciences

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
34 publications in the last five years, latest in 2026.
Senior (last) author on 10 recent papers, a sign of leading a research group.
Principal investigator on 4 research grants (4 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Clostridioides Difficile Infection Clinical Trial Fecal Transplant Fecal Microbiota Transplantation Randomized Clinical Trial Crohn'S Disease Fecal Transplants Microbiome

Latest papers

A pilot randomized trial on the usability and acceptability of an app (MyIBDDiet) to improve the self-management of anti-inflammatory diet for individuals with inflammatory bowel disease: A protocol paper.
PloS one · 2026
Engaging Patient and Caregiver Partners in Codeveloping a Patient Educational Video for Improving Clostridioides difficile Infection Education: Participatory Co-Design Study.
JMIR formative research · 2026 · senior author
Efficacy differentiation of sterile faecal filtrates in Clostridioides difficile infection - Authors' reply.
The lancet. Gastroenterology & hepatology · 2026 · first author

All 79 publications

Latest funding

LyophilizeD fecal micrObiome traNsfer for primAry closTridioides difficilE infection (DONATE study): a multicenter randomized controlled trial
CIHR · 2022 · Nominated PI
$278,485
IMAGINE (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects) SPOR Chronic Disease Network - Knowledge Mobilization & Implementation Science Phase 2
CIHR · 2021 · Principal investigator
$3,745,000
A multicentre, double blind, randomized trial comparing lyophilized fecal filtrate to lyophilized stool in treating recurrent Clostridiodes difficile infection
CIHR · 2019 · Nominated PI
$1,314,115

All 4 grants and awards

79 publications.

A pilot randomized trial on the usability and acceptability of an app (MyIBDDiet) to improve the self-management of anti-inflammatory diet for individuals with inflammatory bowel disease: A protocol paper.

Kaur R, van Diepen K, Raiesdana S, Chappell KD, Ajibulu L, Gozdzik M, Halloran B, Hoentjen F, Kroeker KI, Peerani F, Prado CM, Kao D, Wong K

PloS one2026

DOI: 10.1371/journal.pone.0353123 PMID: 42391282

Engaging Patient and Caregiver Partners in Codeveloping a Patient Educational Video for Improving Clostridioides difficile Infection Education: Participatory Co-Design Study.

Patel RK, Teja R, Hermann K, Franz R, Wong K, Kao D

JMIR formative research2026Senior author

DOI: 10.2196/81643 PMID: 41780918

Efficacy differentiation of sterile faecal filtrates in Clostridioides difficile infection - Authors' reply.

Kao D, Xu H, Louie T

The lancet. Gastroenterology & hepatology2026First author

DOI: 10.1016/s2468-1253(25)00370-x PMID: 41512883

Distinct T and innate-like lymphocyte reprogramming following lyophilized fecal microbiota transplantation in recurrent C. difficile infection.

Gao Y, Shahbaz S, Elahi S, Monaghan TM, LFMT vs LSFF consortium, Kao D

Gut microbes2026

DOI: 10.1080/19490976.2026.2620127 PMID: 41574864

Treatment of Severe and Fulminant Clostridioides difficile Infections.

Weyant RB, Gîlcă-Blanariu GE, Fischer M, Kao D

Gastroenterology clinics of North America2026Senior author

DOI: 10.1016/j.gtc.2026.05.006 PMID: 42538089

Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Remission in Ulcerative Colitis: An Open-Label Pilot Study

Syed S, Moayyedi P, Kao D, Patel J, Marshall JK, Surette M, Narula N

Inflammatory Bowel Diseases20262 citations

DOI: 10.1093/ibd/izaf284

Developing and Evaluating a Bundled Digital Tool to Improve Complex Care and Self-Management of Patients With Inflammatory Bowel Disease: Protocol for a Hybrid Effectiveness-Implementation Study.

Chappell KD, Fox M, Armstrong TS, Ajibulu L, Seow CH, Montano-Loza A, Kroeker KI, Kaplan GG, Novak K, Ma C, Ingram R, Hoentjen F, Halloran B, Peerani F, Kao D, Wong K

JMIR research protocols2025

DOI: 10.2196/65659 PMID: 40749176

Preferred Reporting Items for Microbiotherapy (PRIM) Guidelines Across Medical Disciplines: An International Delphi Consensus.

Zhang F, Kamm MA, Wu X, Kao D, Borody TJ, Chen LA, He X, Fischer M, Wong SH, Ng SC, Cui B, Chan FK, Nie Y, Sood A, Li J, Sun Y, Dai I, Chen Q, Lv M, Zhang Z, Ianiro G, Yang Y, Kelly CR

Journal of gastroenterology and hepatology2025

DOI: 10.1111/jgh.16947 PMID: 40143713

Prolonged effect of antibiotic therapy on the gut microbiota composition, functionality, and antibiotic resistance genes' profiles in healthy stool donors.

Karimianghadim R, Satokari R, Yeo S, Arkkila P, Kao D, Pakpour S

Frontiers in microbiology2025

DOI: 10.3389/fmicb.2025.1589704 PMID: 40415928

LyophilizeD fecal micrObiome traNsfer for primAry closTridioides difficilE infection (DONATE study): a multicenter randomized controlled trial

Nominated PICIHR2022Operating Grant: 14th JPIAMR transnational call for research projects (2022)

Principal investigators: Kao, Dina H

Keywords: Clinical Trial; Clostridioides Difficile Infection; Fecal Transplant

$278,485

IMAGINE (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects) SPOR Chronic Disease Network - Knowledge Mobilization & Implementation Science Phase 2

Principal investigatorCIHR2021SPOR Networks - Knowledge Mobilization and Implementation Science

Principal investigators: Moayyedi, Paul; Calliou, Skylin N; Daley, Kimberlee; De Nino, Alysia; Desjarlais, Rhonda; Marsiglio, Megan L; Munro, Sandra; Baumgart, Daniel C; Bercik, Premysl; Bernstein, Charles N; de Souza, Russell J; Dieleman, Levinus A; D'Silva, Adrijana; Ghia, Jean-Eric; Graff, Lesley A; Jones, Meaghan J; Kao, Dina H; Lavis, John N; Leontiadis, Grigorios; Libertucci, Josie; Ma, Christopher; Madsen, Karen L; Marshall, Deborah A; Narula, Neeraj; Nguyen, Geoffrey C; Otley, Anthony R; Panaccione, Remo; Pena-Sanchez, Juan-Nicolas; Presseau, Justin; Ruzycki, Shannon M; Surette, Michael G; Swain, Mark G; Tandon, Puneeta; Taylor, Valerie Hannah; Tremblay, Melissa; Tripp, Dean A; Vanner, Stephen J; Verdu, Elena F; Walters, Thomas D; Wine, Eytan

Keywords: Anxiety; Depression; Diet; Implementation Science; Inflammatory Bowel Disease; Irritable Bowel Syndrome; Knowledge Mobilization; Microbiome; Patient Orientated Research

$3,745,000

A multicentre, double blind, randomized trial comparing lyophilized fecal filtrate to lyophilized stool in treating recurrent Clostridiodes difficile infection

Nominated PICIHR2019Project Grant

Principal investigators: Kao, Dina H

Keywords: Clostridioides Difficile Infection; Fecal Microbiota Transplantation; Randomized Clinical Trial

$1,314,115

Fecal microbial transplantation in the management of patients with mild-to-moderate Crohn's disease

Principal investigatorCIHR2016Project Grant

Principal investigators: Madsen, Karen L; Fedorak, Richard N; Kao, Dina H; Kaplan, Gilaad G; Kroeker, Karen I

Keywords: Crohn'S Disease; Fecal Transplants; Microbiome

$638,356

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2022

Subject: Prospective PhD student: Clostridioides Difficile Infection Dear Professor Kao, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "A pilot randomized trial on the usability and acceptability of an app (MyIBDDiet) to improve the self-management of anti-inflammatory diet for individuals with inflammatory bowel disease: A protocol paper." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "LyophilizeD fecal micrObiome traNsfer for primAry closTridioides difficilE infection (DONATE study): a multicenter randomized controlled trial" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Dina Kao

Research

Latest papers

Latest funding

A pilot randomized trial on the usability and acceptability of an app (MyIBDDiet) to improve the self-management of anti-inflammatory diet for individuals with inflammatory bowel disease: A protocol paper.

Engaging Patient and Caregiver Partners in Codeveloping a Patient Educational Video for Improving Clostridioides difficile Infection Education: Participatory Co-Design Study.

Efficacy differentiation of sterile faecal filtrates in Clostridioides difficile infection - Authors' reply.

Distinct T and innate-like lymphocyte reprogramming following lyophilized fecal microbiota transplantation in recurrent C. difficile infection.

Treatment of Severe and Fulminant Clostridioides difficile Infections.

Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Remission in Ulcerative Colitis: An Open-Label Pilot Study

Developing and Evaluating a Bundled Digital Tool to Improve Complex Care and Self-Management of Patients With Inflammatory Bowel Disease: Protocol for a Hybrid Effectiveness-Implementation Study.

More questions than answers? Predicting faecal microbiota transplantation outcomes for recurrent Clostridioides difficile infection.

Preferred Reporting Items for Microbiotherapy (PRIM) Guidelines Across Medical Disciplines: An International Delphi Consensus.

Prolonged effect of antibiotic therapy on the gut microbiota composition, functionality, and antibiotic resistance genes' profiles in healthy stool donors.

LyophilizeD fecal micrObiome traNsfer for primAry closTridioides difficilE infection (DONATE study): a multicenter randomized controlled trial

IMAGINE (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects) SPOR Chronic Disease Network - Knowledge Mobilization & Implementation Science Phase 2

A multicentre, double blind, randomized trial comparing lyophilized fecal filtrate to lyophilized stool in treating recurrent Clostridiodes difficile infection

Fecal microbial transplantation in the management of patients with mild-to-moderate Crohn's disease

Frequent collaborators

Puneeta Tandon

Farhad Peerani

Paul Moayyedi

Karen Madsen

Wael Elhenawy

Remo Panaccione

Humberto Jijon

Neeraj Narula

Yasmin Nasser

Matthew Croxen

Christopher Ma

Shima Shahbaz

Harminder Singh

Maryna Yaskina

Karen Kroeker

Troy Perry

Harminder Singh

Emma Allen-Vercoe

Eytan Wine

Paul Beck

Finlay Mcalister

Julia Witt

Andrew Mason

Shokrollah Elahi

Glen Hazlewood

John Kenneth Marshall

Michael Surette